Skip to main content
Signal8

KAKKIS EMIL D

SEC insider (Form 3/4/5 filer). CIK 0001248093. President & CEO at Ultragenyx Pharmaceutical Inc. (RARE). 11 reported Form 4/5 transactions since Sep 2024; latest on Apr 16, 2026. Located in NOVATO, CA.

Companies KAKKIS EMIL D has filed insider reports for

  • Ultragenyx Pharmaceutical Inc. (RARE): Director, Officer, President & CEO
KAKKIS EMIL D profile photo

KAKKIS EMIL D

CIK: 0001248093

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (54.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (9.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ultragenyx Pharmaceutical Inc. logo
RARE

Ultragenyx Pharmaceutical Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Apr 16, 2026
    Award
    Direct
    76.7K shares-
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 2, 2026
    Sale
    Direct
    54.4K shares at avg. $22.80$1.2M
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 1, 2026
    Award
    Direct
    71.2K shares-
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 3, 2025
    Sale
    Direct
    73.4K shares at avg. $42.10$3.1M
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 1, 2025
    Award
    Direct
    43.3K shares-
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Mar 1, 2025
    Award
    Direct
    107.3K shares-
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Feb 28, 2025
    Sale
    Indirect
    25K shares at avg. $42.48$1.1M
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Dec 30, 2024
    Sale
    Indirect
    11.7K shares at avg. $42.23$495K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Dec 10, 2024
    Sale
    Indirect
    8.3K shares at avg. $50.00$414K
  • Ultragenyx Pharmaceutical Inc. logo
    RARE

    Ultragenyx Pharmaceutical Inc.

    Dec 9, 2024
    Gift
    Indirect
    20K shares-

1-10 of 11